Hepatic dysfunction associated with renal transplantation.
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D056486:Chemical and Drug Induced Liver Injury; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000209:etiology; D005260:Female; D006506:Hepatitis A / Q000209:etiology; D006564:Herpesviridae / Q000302:isolation & purification; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008099:Liver / Q000187:drug effects; D008107:Liver Diseases / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D009336:Necrosis; D010530:Peritoneal Dialysis; D011183:Postoperative Complications; D006435:Renal Dialysis; D014019:Tissue Donors; D014184:Transplantation, Homologous
D001798:Blood Proteins; D007166:Immunosuppressive Agents; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin